Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy. Padmanee Sharma, Siwen Hu-Lieskovan, Jennifer A Wargo, Antoni Ribas. Cell, 2017 Feb 12; 168(4). PMID: 28187290 Free PMC article. Highly Cited. Review.
|
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors. Jonathan M Pitt, Marie Vétizou, +8 authors, Romain Daillère, María Paula Roberti, Takahiro Yamazaki, Bertrand Routy, Patricia Lepage, Ivo Gomperts Boneca, Mathias Chamaillard, Guido Kroemer, Laurence Zitvogel. less Immunity, 2016 Jun 23; 44(6). PMID: 27332730 Highly Cited. Review.
|
Immune checkpoint blockade: a common denominator approach to cancer therapy. Suzanne L Topalian, Charles G Drake, Drew M Pardoll. Cancer Cell, 2015 Apr 11; 27(4). PMID: 25858804 Free PMC article. Highly Cited. Review.
|
Genetic basis for clinical response to CTLA-4 blockade in melanoma. Alexandra Snyder, Vladimir Makarov, +18 authors, Taha Merghoub, Jianda Yuan, Jesse M Zaretsky, Alexis Desrichard, Logan A Walsh, Michael A Postow, Phillip Wong, Teresa S Ho, Travis J Hollmann, Cameron Bruggeman, Kasthuri Kannan, Yanyun Li, Ceyhan Elipenahli, Cailian Liu, Christopher T Harbison, Lisu Wang, Antoni Ribas, Jedd D Wolchok, Timothy A Chan. less N Engl J Med, 2014 Nov 20; 371(23). PMID: 25409260 Free PMC article. Highly Cited.
|
Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. D H Kaplan, V Shankaran, +4 authors, A S Dighe, E Stockert, M Aguet, L J Old, R D Schreiber. less Proc Natl Acad Sci U S A, 1998 Jun 24; 95(13). PMID: 9636188 Free PMC article. Highly Cited.
|
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma. Robert J Motzer, Bernard Escudier, +25 authors, David F McDermott, Saby George, Hans J Hammers, Sandhya Srinivas, Scott S Tykodi, Jeffrey A Sosman, Giuseppe Procopio, Elizabeth R Plimack, Daniel Castellano, Toni K Choueiri, Howard Gurney, Frede Donskov, Petri Bono, John Wagstaff, Thomas C Gauler, Takeshi Ueda, Yoshihiko Tomita, Fabio A Schutz, Christian Kollmannsberger, James Larkin, Alain Ravaud, Jason S Simon, Li-An Xu, Ian M Waxman, Padmanee Sharma, CheckMate 025 Investigators. less N Engl J Med, 2015 Sep 26; 373(19). PMID: 26406148 Free PMC article. Highly Cited.
|
Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer. Scott Gettinger, Jungmin Choi, +23 authors, Katherine Hastings, Anna Truini, Ila Datar, Ryan Sowell, Anna Wurtz, Weilai Dong, Guoping Cai, Mary Ann Melnick, Victor Y Du, Joseph Schlessinger, Sarah B Goldberg, Anne Chiang, Miguel F Sanmamed, Ignacio Melero, Jackeline Agorreta, Luis M Montuenga, Richard Lifton, Soldano Ferrone, Paula Kavathas, David L Rimm, Susan M Kaech, Kurt Schalper, Roy S Herbst, Katerina Politi. less Cancer Discov, 2017 Oct 14; 7(12). PMID: 29025772 Free PMC article. Highly Cited.
|
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab. Nadeem Riaz, Jonathan J Havel, +22 authors, Vladimir Makarov, Alexis Desrichard, Walter J Urba, Jennifer S Sims, F Stephen Hodi, Salvador Martín-Algarra, Rajarsi Mandal, William H Sharfman, Shailender Bhatia, Wen-Jen Hwu, Thomas F Gajewski, Craig L Slingluff, Diego Chowell, Sviatoslav M Kendall, Han Chang, Rachna Shah, Fengshen Kuo, Luc G T Morris, John-William Sidhom, Jonathan P Schneck, Christine E Horak, Nils Weinhold, Timothy A Chan. less Cell, 2017 Oct 17; 171(4). PMID: 29033130 Free PMC article. Highly Cited.
|
PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer. Nisha Nagarsheth, Dongjun Peng, +15 authors, Ilona Kryczek, Ke Wu, Wei Li, Ende Zhao, Lili Zhao, Shuang Wei, Timothy Frankel, Linda Vatan, Wojciech Szeliga, Yali Dou, Scott Owens, Victor Marquez, Kaixiong Tao, Emina Huang, Guobin Wang, Weiping Zou. less Cancer Res, 2015 Nov 15; 76(2). PMID: 26567139 Free PMC article. Highly Cited.
|
Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Naiyer A Rizvi, Matthew D Hellmann, +21 authors, Alexandra Snyder, Pia Kvistborg, Vladimir Makarov, Jonathan J Havel, William Lee, Jianda Yuan, Phillip Wong, Teresa S Ho, Martin L Miller, Natasha Rekhtman, Andre L Moreira, Fawzia Ibrahim, Cameron Bruggeman, Billel Gasmi, Roberta Zappasodi, Yuka Maeda, Chris Sander, Edward B Garon, Taha Merghoub, Jedd D Wolchok, Ton N Schumacher, Timothy A Chan. less Science, 2015 Mar 15; 348(6230). PMID: 25765070 Free PMC article. Highly Cited.
|
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. Eliezer M Van Allen, Diana Miao, +19 authors, Bastian Schilling, Sachet A Shukla, Christian Blank, Lisa Zimmer, Antje Sucker, Uwe Hillen, Marnix H Geukes Foppen, Simone M Goldinger, Jochen Utikal, Jessica C Hassel, Benjamin Weide, Katharina C Kaehler, Carmen Loquai, Peter Mohr, Ralf Gutzmer, Reinhard Dummer, Stacey Gabriel, Catherine J Wu, Dirk Schadendorf, Levi A Garraway. less Science, 2015 Sep 12; 350(6257). PMID: 26359337 Free PMC article. Highly Cited.
|
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial. Jonathan E Rosenberg, Jean Hoffman-Censits, +28 authors, Tom Powles, Michiel S van der Heijden, Arjun V Balar, Andrea Necchi, Nancy Dawson, Peter H O'Donnell, Ani Balmanoukian, Yohann Loriot, Sandy Srinivas, Margitta M Retz, Petros Grivas, Richard W Joseph, Matthew D Galsky, Mark T Fleming, Daniel P Petrylak, Jose Luis Perez-Gracia, Howard A Burris, Daniel Castellano, Christina Canil, Joaquim Bellmunt, Dean Bajorin, Dorothee Nickles, Richard Bourgon, Garrett M Frampton, Na Cui, Sanjeev Mariathasan, Oyewale Abidoye, Gregg D Fine, Robert Dreicer. less Lancet, 2016 Mar 10; 387(10031). PMID: 26952546 Free PMC article. Highly Cited.
|
Resistance to checkpoint blockade therapy through inactivation of antigen presentation. Moshe Sade-Feldman, Yunxin J Jiao, +28 authors, Jonathan H Chen, Michael S Rooney, Michal Barzily-Rokni, Jean-Pierre Eliane, Stacey L Bjorgaard, Marc R Hammond, Hans Vitzthum, Shauna M Blackmon, Dennie T Frederick, Mehlika Hazar-Rethinam, Brandon A Nadres, Emily E Van Seventer, Sachet A Shukla, Keren Yizhak, John P Ray, Daniel Rosebrock, Dimitri Livitz, Viktor Adalsteinsson, Gad Getz, Lyn M Duncan, Bo Li, Ryan B Corcoran, Donald P Lawrence, Anat Stemmer-Rachamimov, Genevieve M Boland, Dan A Landau, Keith T Flaherty, Ryan J Sullivan, Nir Hacohen. less Nat Commun, 2017 Oct 27; 8(1). PMID: 29070816 Free PMC article. Highly Cited.
|
Adoptive T cell therapy promotes the emergence of genomically altered tumor escape variants. Karen M Kaluza, Jill M Thompson, +3 authors, Timothy J Kottke, Heather C Flynn Gilmer, Darlene L Knutson, Richard G Vile. less Int J Cancer, 2011 Sep 22; 131(4). PMID: 21935923 Free PMC article.
|
Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. Paul F Robbins, Richard A Morgan, +18 authors, Steven A Feldman, James C Yang, Richard M Sherry, Mark E Dudley, John R Wunderlich, Azam V Nahvi, Lee J Helman, Crystal L Mackall, Udai S Kammula, Marybeth S Hughes, Nicholas P Restifo, Mark Raffeld, Chyi-Chia Richard Lee, Catherine L Levy, Yong F Li, Mona El-Gamil, Susan L Schwarz, Carolyn Laurencot, Steven A Rosenberg. less J Clin Oncol, 2011 Feb 02; 29(7). PMID: 21282551 Free PMC article. Highly Cited.
|
Improved survival with ipilimumab in patients with metastatic melanoma. F Stephen Hodi, Steven J O'Day, +26 authors, David F McDermott, Robert W Weber, Jeffrey A Sosman, John B Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C Hassel, Wallace Akerley, Alfons J M van den Eertwegh, Jose Lutzky, Paul Lorigan, Julia M Vaubel, Gerald P Linette, David Hogg, Christian H Ottensmeier, Celeste Lebbé, Christian Peschel, Ian Quirt, Joseph I Clark, Jedd D Wolchok, Jeffrey S Weber, Jason Tian, Michael J Yellin, Geoffrey M Nichol, Axel Hoos, Walter J Urba. less N Engl J Med, 2010 Jun 08; 363(8). PMID: 20525992 Free PMC article. Highly Cited.
|
Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells. Mark J Selby, John J Engelhardt, +4 authors, Michael Quigley, Karla A Henning, Timothy Chen, Mohan Srinivasan, Alan J Korman. less Cancer Immunol Res, 2014 Apr 30; 1(1). PMID: 24777248 Highly Cited.
|
Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial. Evan W Alley, Juanita Lopez, +4 authors, Armando Santoro, Anne Morosky, Sanatan Saraf, Bilal Piperdi, Emilie van Brummelen. less Lancet Oncol, 2017 Mar 16; 18(5). PMID: 28291584 Highly Cited.
|
Chimeric antigen receptor T cells for sustained remissions in leukemia. Shannon L Maude, Noelle Frey, +16 authors, Pamela A Shaw, Richard Aplenc, David M Barrett, Nancy J Bunin, Anne Chew, Vanessa E Gonzalez, Zhaohui Zheng, Simon F Lacey, Yolanda D Mahnke, Jan J Melenhorst, Susan R Rheingold, Angela Shen, David T Teachey, Bruce L Levine, Carl H June, David L Porter, Stephan A Grupp. less N Engl J Med, 2014 Oct 16; 371(16). PMID: 25317870 Free PMC article. Highly Cited.
|
PD-1 and its ligands in tolerance and immunity. Mary E Keir, Manish J Butte, Gordon J Freeman, Arlene H Sharpe. Annu Rev Immunol, 2008 Jan 05; 26. PMID: 18173375 Highly Cited. Review.
|
Interferon receptor signaling in malignancy: a network of cellular pathways defining biological outcomes. Eleanor N Fish, Leonidas C Platanias. Mol Cancer Res, 2014 Sep 14; 12(12). PMID: 25217450 Free PMC article. Review.
|
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial. Padmanee Sharma, Margitta Retz, +16 authors, Arlene Siefker-Radtke, Ari Baron, Andrea Necchi, Jens Bedke, Elizabeth R Plimack, Daniel Vaena, Marc-Oliver Grimm, Sergio Bracarda, José Ángel Arranz, Sumanta Pal, Chikara Ohyama, Abdel Saci, Xiaotao Qu, Alexandre Lambert, Suba Krishnan, Alex Azrilevich, Matthew D Galsky. less Lancet Oncol, 2017 Jan 31; 18(3). PMID: 28131785 Highly Cited.
|
Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial. Kevin J Harrington, Robert L Ferris, +21 authors, George Blumenschein, A Dimitrios Colevas, Jérôme Fayette, Lisa Licitra, Stefan Kasper, Caroline Even, Everett E Vokes, Francis Worden, Nabil F Saba, Naomi Kiyota, Robert Haddad, Makoto Tahara, Viktor Grünwald, James W Shaw, Manish Monga, Mark Lynch, Fiona Taylor, Michael DeRosa, Laura Morrissey, Kim Cocks, Maura L Gillison, Joël Guigay. less Lancet Oncol, 2017 Jun 28; 18(8). PMID: 28651929 Free PMC article. Highly Cited.
|
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma. Dirk Schadendorf, F Stephen Hodi, +7 authors, Caroline Robert, Jeffrey S Weber, Kim Margolin, Omid Hamid, Debra Patt, Tai-Tsang Chen, David M Berman, Jedd D Wolchok. less J Clin Oncol, 2015 Feb 11; 33(17). PMID: 25667295 Free PMC article. Highly Cited.
|
Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation. Jennifer Landsberg, Judith Kohlmeyer, +8 authors, Marcel Renn, Tobias Bald, Meri Rogava, Mira Cron, Martina Fatho, Volker Lennerz, Thomas Wölfel, Michael Hölzel, Thomas Tüting. less Nature, 2012 Oct 12; 490(7420). PMID: 23051752 Highly Cited.
|
Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006). Jacob Schachter, Antoni Ribas, +17 authors, Georgina V Long, Ana Arance, Jean-Jacques Grob, Laurent Mortier, Adil Daud, Matteo S Carlino, Catriona McNeil, Michal Lotem, James Larkin, Paul Lorigan, Bart Neyns, Christian Blank, Teresa M Petrella, Omid Hamid, Honghong Zhou, Scot Ebbinghaus, Nageatte Ibrahim, Caroline Robert. less Lancet, 2017 Aug 22; 390(10105). PMID: 28822576 Highly Cited.
|
Acquired resistance to anti-PD1 therapy: checkmate to checkpoint blockade? Jake S O'Donnell, Mark J Smyth, Michele W L Teng. Genome Med, 2016 Oct 27; 8(1). PMID: 27782862 Free PMC article.
|
IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expression. Gavin P Dunn, Kathleen C F Sheehan, Lloyd J Old, Robert D Schreiber. Cancer Res, 2005 Apr 19; 65(8). PMID: 15833880
|
Adoptive immunotherapy for cancer: harnessing the T cell response. Nicholas P Restifo, Mark E Dudley, Steven A Rosenberg. Nat Rev Immunol, 2012 Mar 23; 12(4). PMID: 22437939 Free PMC article. Highly Cited. Review.
|
T-cell receptor gene therapy--ready to go viral? Terhi Karpanen, Johanna Olweus. Mol Oncol, 2015 Nov 10; 9(10). PMID: 26548533 Free PMC article. Review.
|
Epigenetic modulation in cancer immunotherapy. Stuart J Gallagher, Elena Shklovskaya, Peter Hersey. Curr Opin Pharmacol, 2017 Jun 14; 35. PMID: 28609681 Review.
|
Molecular and genetic properties of tumors associated with local immune cytolytic activity. Michael S Rooney, Sachet A Shukla, +2 authors, Catherine J Wu, Gad Getz, Nir Hacohen. less Cell, 2015 Jan 17; 160(1-2). PMID: 25594174 Free PMC article. Highly Cited.
|
Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer. Gulidanna Shayan, Raghvendra Srivastava, +3 authors, Jing Li, Nicole Schmitt, Lawrence P Kane, Robert L Ferris. less Oncoimmunology, 2017 Feb 16; 6(1). PMID: 28197389 Free PMC article. Highly Cited.
|
Immune monitoring of the circulation and the tumor microenvironment in patients with regionally advanced melanoma receiving neoadjuvant ipilimumab. Ahmad A Tarhini, Howard Edington, +9 authors, Lisa H Butterfield, Yan Lin, Yongli Shuai, Hussein Tawbi, Cindy Sander, Yan Yin, Matthew Holtzman, Jonas Johnson, Uma N M Rao, John M Kirkwood. less PLoS One, 2014 Feb 06; 9(2). PMID: 24498358 Free PMC article. Highly Cited.
|
The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer. Jeffrey P Ward, Matthew M Gubin, Robert D Schreiber. Adv Immunol, 2016 Mar 01; 130. PMID: 26922999 Free PMC article. Highly Cited. Review.
|
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies. Frederick Arce Vargas, Andrew J S Furness, +32 authors, Kevin Litchfield, Kroopa Joshi, Rachel Rosenthal, Ehsan Ghorani, Isabelle Solomon, Marta H Lesko, Nora Ruef, Claire Roddie, Jake Y Henry, Lavinia Spain, Assma Ben Aissa, Andrew Georgiou, Yien Ning Sophia Wong, Myles Smith, Dirk Strauss, Andrew Hayes, David Nicol, Tim O'Brien, Linda Mårtensson, Anne Ljungars, Ingrid Teige, Björn Frendéus, TRACERx Melanoma, TRACERx Renal, TRACERx Lung consortia, Martin Pule, Teresa Marafioti, Martin Gore, James Larkin, Samra Turajlic, Charles Swanton, Karl S Peggs, Sergio A Quezada. less Cancer Cell, 2018 Mar 27; 33(4). PMID: 29576375 Free PMC article. Highly Cited.
|
De-novo and acquired resistance to immune checkpoint targeting. Nicholas L Syn, Michele W L Teng, Tony S K Mok, Ross A Soo. Lancet Oncol, 2017 Dec 07; 18(12). PMID: 29208439 Highly Cited. Review.
|
Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies. Yannick Bulliard, Rose Jolicoeur, +6 authors, Maurice Windman, Sarah M Rue, Seth Ettenberg, Deborah A Knee, Nicholas S Wilson, Glenn Dranoff, Jennifer L Brogdon. less J Exp Med, 2013 Jul 31; 210(9). PMID: 23897982 Free PMC article. Highly Cited.
|
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Ugur Sahin, Evelyna Derhovanessian, +47 authors, Matthias Miller, Björn-Philipp Kloke, Petra Simon, Martin Löwer, Valesca Bukur, Arbel D Tadmor, Ulrich Luxemburger, Barbara Schrörs, Tana Omokoko, Mathias Vormehr, Christian Albrecht, Anna Paruzynski, Andreas N Kuhn, Janina Buck, Sandra Heesch, Katharina H Schreeb, Felicitas Müller, Inga Ortseifer, Isabel Vogler, Eva Godehardt, Sebastian Attig, Richard Rae, Andrea Breitkreuz, Claudia Tolliver, Martin Suchan, Goran Martic, Alexander Hohberger, Patrick Sorn, Jan Diekmann, Janko Ciesla, Olga Waksmann, Alexandra-Kemmer Brück, Meike Witt, Martina Zillgen, Andree Rothermel, Barbara Kasemann, David Langer, Stefanie Bolte, Mustafa Diken, Sebastian Kreiter, Romina Nemecek, Christoffer Gebhardt, Stephan Grabbe, Christoph Höller, Jochen Utikal, Christoph Huber, Carmen Loquai, Özlem Türeci. less Nature, 2017 Jul 06; 547(7662). PMID: 28678784 Highly Cited.
|
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. Martin Reck, Delvys Rodríguez-Abreu, +16 authors, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe, Mary O'Brien, Suman Rao, Katsuyuki Hotta, Melanie A Leiby, Gregory M Lubiniecki, Yue Shentu, Reshma Rangwala, Julie R Brahmer, KEYNOTE-024 Investigators. less N Engl J Med, 2016 Oct 11; 375(19). PMID: 27718847 Highly Cited.
|
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial. Howard L Kaufman, Jeffery Russell, +15 authors, Omid Hamid, Shailender Bhatia, Patrick Terheyden, Sandra P D'Angelo, Kent C Shih, Céleste Lebbé, Gerald P Linette, Michele Milella, Isaac Brownell, Karl D Lewis, Jochen H Lorch, Kevin Chin, Lisa Mahnke, Anja von Heydebreck, Jean-Marie Cuillerot, Paul Nghiem. less Lancet Oncol, 2016 Sep 07; 17(10). PMID: 27592805 Free PMC article. Highly Cited.
|
Adaptive Immune Resistance: How Cancer Protects from Immune Attack. Antoni Ribas. Cancer Discov, 2015 Aug 15; 5(9). PMID: 26272491 Free PMC article. Highly Cited. Review.
|
Recent clinical trials utilizing chimeric antigen receptor T cells therapies against solid tumors. Shuanglin Han, Olivier Latchoumanin, +4 authors, Guang Wu, Gang Zhou, Lionel Hebbard, Jacob George, Liang Qiao. less Cancer Lett, 2017 Jan 17; 390. PMID: 28089834 Review.
|
T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer. Eric Tran, Paul F Robbins, +9 authors, Yong-Chen Lu, Todd D Prickett, Jared J Gartner, Li Jia, Anna Pasetto, Zhili Zheng, Satyajit Ray, Eric M Groh, Isaac R Kriley, Steven A Rosenberg. less N Engl J Med, 2016 Dec 14; 375(23). PMID: 27959684 Free PMC article. Highly Cited.
|
Tumor-infiltrating lymphocytes for the treatment of metastatic cancer. M H Geukes Foppen, M Donia, I M Svane, J B A G Haanen. Mol Oncol, 2015 Nov 19; 9(10). PMID: 26578452 Free PMC article. Review.
|
Nivolumab and ipilimumab versus ipilimumab in untreated melanoma. Michael A Postow, Jason Chesney, +18 authors, Anna C Pavlick, Caroline Robert, Kenneth Grossmann, David McDermott, Gerald P Linette, Nicolas Meyer, Jeffrey K Giguere, Sanjiv S Agarwala, Montaser Shaheen, Marc S Ernstoff, David Minor, April K Salama, Matthew Taylor, Patrick A Ott, Linda M Rollin, Christine Horak, Paul Gagnier, Jedd D Wolchok, F Stephen Hodi. less N Engl J Med, 2015 Apr 22; 372(21). PMID: 25891304 Free PMC article. Highly Cited.
|
Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations. Daniel Sanghoon Shin, Jesse M Zaretsky, +24 authors, Helena Escuin-Ordinas, Angel Garcia-Diaz, Siwen Hu-Lieskovan, Anusha Kalbasi, Catherine S Grasso, Willy Hugo, Salemiz Sandoval, Davis Y Torrejon, Nicolaos Palaskas, Gabriel Abril Rodriguez, Giulia Parisi, Ariel Azhdam, Bartosz Chmielowski, Grace Cherry, Elizabeth Seja, Beata Berent-Maoz, I Peter Shintaku, Dung T Le, Drew M Pardoll, Luis A Diaz, Paul C Tumeh, Thomas G Graeber, Roger S Lo, Begoña Comin-Anduix, Antoni Ribas. less Cancer Discov, 2016 Dec 03; 7(2). PMID: 27903500 Free PMC article. Highly Cited.
|
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer. Hossein Borghaei, Luis Paz-Ares, +25 authors, Leora Horn, David R Spigel, Martin Steins, Neal E Ready, Laura Q Chow, Everett E Vokes, Enriqueta Felip, Esther Holgado, Fabrice Barlesi, Martin Kohlhäufl, Oscar Arrieta, Marco Angelo Burgio, Jérôme Fayette, Hervé Lena, Elena Poddubskaya, David E Gerber, Scott N Gettinger, Charles M Rudin, Naiyer Rizvi, Lucio Crinò, George R Blumenschein, Scott J Antonia, Cécile Dorange, Christopher T Harbison, Friedrich Graf Finckenstein, Julie R Brahmer. less N Engl J Med, 2015 Sep 29; 373(17). PMID: 26412456 Free PMC article. Highly Cited.
|
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer. Jianjun Gao, John F Ward, +16 authors, Curtis A Pettaway, Lewis Z Shi, Sumit K Subudhi, Luis M Vence, Hao Zhao, Jianfeng Chen, Hong Chen, Eleni Efstathiou, Patricia Troncoso, James P Allison, Christopher J Logothetis, Ignacio I Wistuba, Manuel A Sepulveda, Jingjing Sun, Jennifer Wargo, Jorge Blando, Padmanee Sharma. less Nat Med, 2017 Mar 28; 23(5). PMID: 28346412 Free PMC article. Highly Cited.
|
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer. Valsamo Anagnostou, Kellie N Smith, +26 authors, Patrick M Forde, Noushin Niknafs, Rohit Bhattacharya, James White, Theresa Zhang, Vilmos Adleff, Jillian Phallen, Neha Wali, Carolyn Hruban, Violeta B Guthrie, Kristen Rodgers, Jarushka Naidoo, Hyunseok Kang, William Sharfman, Christos Georgiades, Franco Verde, Peter Illei, Qing Kay Li, Edward Gabrielson, Malcolm V Brock, Cynthia A Zahnow, Stephen B Baylin, Robert B Scharpf, Julie R Brahmer, Rachel Karchin, Drew M Pardoll, Victor E Velculescu. less Cancer Discov, 2016 Dec 30; 7(3). PMID: 28031159 Free PMC article. Highly Cited.
|
CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. M F Krummel, J P Allison. J Exp Med, 1995 Aug 01; 182(2). PMID: 7543139 Free PMC article. Highly Cited.
|
Mechanisms of resistance to immune checkpoint inhibitors. Russell W Jenkins, David A Barbie, Keith T Flaherty. Br J Cancer, 2018 Jan 11; 118(1). PMID: 29319049 Free PMC article. Highly Cited. Review.
|
Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma. Robert Chen, Pier Luigi Zinzani, +15 authors, Michelle A Fanale, Philippe Armand, Nathalie A Johnson, Pauline Brice, John Radford, Vincent Ribrag, Daniel Molin, Theodoros P Vassilakopoulos, Akihiro Tomita, Bastian von Tresckow, Margaret A Shipp, Yinghua Zhang, Alejandro D Ricart, Arun Balakumaran, Craig H Moskowitz, KEYNOTE-087. less J Clin Oncol, 2017 Apr 26; 35(19). PMID: 28441111 Free PMC article. Highly Cited.
|
Immunoediting of cancers may lead to epithelial to mesenchymal transition. Keith L Knutson, Hailing Lu, +6 authors, Brad Stone, Jennifer M Reiman, Marshall D Behrens, Christine M Prosperi, Ekram A Gad, Arianna Smorlesi, Mary L Disis. less J Immunol, 2006 Jul 20; 177(3). PMID: 16849459
|
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade. Joseph L Benci, Bihui Xu, +16 authors, Yu Qiu, Tony J Wu, Hannah Dada, Christina Twyman-Saint Victor, Lisa Cucolo, David S M Lee, Kristen E Pauken, Alexander C Huang, Tara C Gangadhar, Ravi K Amaravadi, Lynn M Schuchter, Michael D Feldman, Hemant Ishwaran, Robert H Vonderheide, Amit Maity, E John Wherry, Andy J Minn. less Cell, 2016 Dec 03; 167(6). PMID: 27912061 Free PMC article. Highly Cited.
|
Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling. Marco Donia, Katja Harbst, +20 authors, Marit van Buuren, Pia Kvistborg, Mattias F Lindberg, Rikke Andersen, Manja Idorn, Shamaila Munir Ahmad, Eva Ellebæk, Anja Mueller, Paolo Fagone, Ferdinando Nicoletti, Massimo Libra, Martin Lauss, Sine Reker Hadrup, Henrik Schmidt, Mads Hald Andersen, Per Thor Straten, Jonas A Nilsson, Ton N Schumacher, Barbara Seliger, Göran Jönsson, Inge Marie Svane. less Cancer Res, 2017 Jun 29; 77(17). PMID: 28655789
|
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma. Paul T Nghiem, Shailender Bhatia, +28 authors, Evan J Lipson, Ragini R Kudchadkar, Natalie J Miller, Lakshmanan Annamalai, Sneha Berry, Elliot K Chartash, Adil Daud, Steven P Fling, Philip A Friedlander, Harriet M Kluger, Holbrook E Kohrt, Lisa Lundgren, Kim Margolin, Alan Mitchell, Thomas Olencki, Drew M Pardoll, Sunil A Reddy, Erica M Shantha, William H Sharfman, Elad Sharon, Lynn R Shemanski, Michi M Shinohara, Joel C Sunshine, Janis M Taube, John A Thompson, Steven M Townson, Jennifer H Yearley, Suzanne L Topalian, Martin A Cheever. less N Engl J Med, 2016 Apr 20; 374(26). PMID: 27093365 Free PMC article. Highly Cited.
|
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma. Antoni Ribas, Omid Hamid, +25 authors, Adil Daud, F Stephen Hodi, Jedd D Wolchok, Richard Kefford, Anthony M Joshua, Amita Patnaik, Wen-Jen Hwu, Jeffrey S Weber, Tara C Gangadhar, Peter Hersey, Roxana Dronca, Richard W Joseph, Hassane Zarour, Bartosz Chmielowski, Donald P Lawrence, Alain Algazi, Naiyer A Rizvi, Brianna Hoffner, Christine Mateus, Kevin Gergich, Jill A Lindia, Maxine Giannotti, Xiaoyun Nicole Li, Scot Ebbinghaus, S Peter Kang, Caroline Robert. less JAMA, 2016 Apr 20; 315(15). PMID: 27092830 Highly Cited.
|
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial. Tanguy Y Seiwert, Barbara Burtness, +9 authors, Ranee Mehra, Jared Weiss, Raanan Berger, Joseph Paul Eder, Karl Heath, Terrill McClanahan, Jared Lunceford, Christine Gause, Jonathan D Cheng, Laura Q Chow. less Lancet Oncol, 2016 Jun 02; 17(7). PMID: 27247226 Highly Cited.
|
Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival. Scott D Brown, Rene L Warren, +4 authors, Ewan A Gibb, Spencer D Martin, John J Spinelli, Brad H Nelson, Robert A Holt. less Genome Res, 2014 May 02; 24(5). PMID: 24782321 Free PMC article. Highly Cited.
|
Paradoxical effects of interleukin-10 on the maturation of murine myeloid dendritic cells. Dianne L Commeren, Peter L Van Soest, +3 authors, Khalil Karimi, Bob Löwenberg, Jan J Cornelissen, Eric Braakman. less Immunology, 2003 Sep 27; 110(2). PMID: 14511232 Free PMC article.
|
Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients. Emanuela Romano, Monika Kusio-Kobialka, +7 authors, Periklis G Foukas, Petra Baumgaertner, Christiane Meyer, Pierluigi Ballabeni, Olivier Michielin, Benjamin Weide, Pedro Romero, Daniel E Speiser. less Proc Natl Acad Sci U S A, 2015 Apr 29; 112(19). PMID: 25918390 Free PMC article. Highly Cited.
|
Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions. Antje Sucker, Fang Zhao, +20 authors, Natalia Pieper, Christina Heeke, Raffaela Maltaner, Nadine Stadtler, Birgit Real, Nicola Bielefeld, Sebastian Howe, Benjamin Weide, Ralf Gutzmer, Jochen Utikal, Carmen Loquai, Helen Gogas, Ludger Klein-Hitpass, Michael Zeschnigk, Astrid M Westendorf, Mirko Trilling, Susanne Horn, Bastian Schilling, Dirk Schadendorf, Klaus G Griewank, Annette Paschen. less Nat Commun, 2017 Jun 01; 8. PMID: 28561041 Free PMC article. Highly Cited.
|
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. James Larkin, Vanna Chiarion-Sileni, +28 authors, Rene Gonzalez, Jean Jacques Grob, C Lance Cowey, Christopher D Lao, Dirk Schadendorf, Reinhard Dummer, Michael Smylie, Piotr Rutkowski, Pier F Ferrucci, Andrew Hill, John Wagstaff, Matteo S Carlino, John B Haanen, Michele Maio, Ivan Marquez-Rodas, Grant A McArthur, Paolo A Ascierto, Georgina V Long, Margaret K Callahan, Michael A Postow, Kenneth Grossmann, Mario Sznol, Brigitte Dreno, Lars Bastholt, Arvin Yang, Linda M Rollin, Christine Horak, F Stephen Hodi, Jedd D Wolchok. less N Engl J Med, 2015 Jun 02; 373(1). PMID: 26027431 Free PMC article. Highly Cited.
|
Pharmacokinetic drug evaluation of talimogene laherparepvec for the treatment of advanced melanoma. Erin E Burke, Jonathan S Zager. Expert Opin Drug Metab Toxicol, 2018 Mar 21; 14(4). PMID: 29557682 Review.
|
TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma. Florie Bertrand, Anne Montfort, +9 authors, Elie Marcheteau, Caroline Imbert, Julia Gilhodes, Thomas Filleron, Philippe Rochaix, Nathalie Andrieu-Abadie, Thierry Levade, Nicolas Meyer, Céline Colacios, Bruno Ségui. less Nat Commun, 2017 Dec 24; 8(1). PMID: 29273790 Free PMC article. Highly Cited.
|
Exploiting CTLA-4, PD-1 and PD-L1 to reactivate the host immune response against cancer. S A Quezada, K S Peggs. Br J Cancer, 2013 Mar 21; 108(8). PMID: 23511566 Free PMC article.
|
Neoantigens in cancer immunotherapy. Ton N Schumacher, Robert D Schreiber. Science, 2015 Apr 04; 348(6230). PMID: 25838375 Highly Cited. Review.
|
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy. Antoni Ribas, Reinhard Dummer, +17 authors, Igor Puzanov, Ari VanderWalde, Robert H I Andtbacka, Olivier Michielin, Anthony J Olszanski, Josep Malvehy, Jonathan Cebon, Eugenio Fernandez, John M Kirkwood, Thomas F Gajewski, Lisa Chen, Kevin S Gorski, Abraham A Anderson, Scott J Diede, Michael E Lassman, Jennifer Gansert, F Stephen Hodi, Georgina V Long. less Cell, 2017 Sep 09; 170(6). PMID: 28886381 Free PMC article. Highly Cited.
|
Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape. Seng-Ryong Woo, Meghan E Turnis, +18 authors, Monica V Goldberg, Jaishree Bankoti, Mark Selby, Christopher J Nirschl, Matthew L Bettini, David M Gravano, Peter Vogel, Chih Long Liu, Stephanie Tangsombatvisit, Joseph F Grosso, George Netto, Matthew P Smeltzer, Alcides Chaux, Paul J Utz, Creg J Workman, Drew M Pardoll, Alan J Korman, Charles G Drake, Dario A A Vignali. less Cancer Res, 2011 Dec 22; 72(4). PMID: 22186141 Free PMC article. Highly Cited.
|
Corrigendum: An immunogenic personal neoantigen vaccine for patients with melanoma. Patrick A Ott, Zhuting Hu, +37 authors, Derin B Keskin, Sachet A Shukla, Jing Sun, David J Bozym, Wandi Zhang, Adrienne Luoma, Anita Giobbie-Hurder, Lauren Peter, Christina Chen, Oriol Olive, Todd A Carter, Shuqiang Li, David J Lieb, Thomas Eisenhaure, Evisa Gjini, Jonathan Stevens, William J Lane, Indu Javeri, Kaliappanadar Nellaiappan, Andres M Salazar, Heather Daley, Michael Seaman, Elizabeth I Buchbinder, Charles H Yoon, Maegan Harden, Niall Lennon, Stacey Gabriel, Scott J Rodig, Dan H Barouch, Jon C Aster, Gad Getz, Kai Wucherpfennig, Donna Neuberg, Jerome Ritz, Eric S Lander, Edward F Fritsch, Nir Hacohen, Catherine J Wu. less Nature, 2018 Mar 16; 555(7696). PMID: 29542692 Free PMC article.
|
Neoantigen landscape dynamics during human melanoma-T cell interactions. Els M E Verdegaal, Noel F C C de Miranda, +11 authors, Marten Visser, Tom Harryvan, Marit M van Buuren, Rikke S Andersen, Sine R Hadrup, Caroline E van der Minne, Remko Schotte, Hergen Spits, John B A G Haanen, Ellen H W Kapiteijn, Ton N Schumacher, Sjoerd H van der Burg. less Nature, 2016 Jun 29; 536(7614). PMID: 27350335 Highly Cited.
|
Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study. Thomas Powles, Peter H O'Donnell, +16 authors, Christophe Massard, Hendrik-Tobias Arkenau, Terence W Friedlander, Christopher J Hoimes, Jae Lyun Lee, Michael Ong, Srikala S Sridhar, Nicholas J Vogelzang, Mayer N Fishman, Jingsong Zhang, Sandy Srinivas, Jigar Parikh, Joyce Antal, Xiaoping Jin, Ashok K Gupta, Yong Ben, Noah M Hahn. less JAMA Oncol, 2017 Aug 18; 3(9). PMID: 28817753 Free PMC article. Highly Cited.
|
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. Caroline Robert, Luc Thomas, +21 authors, Igor Bondarenko, Steven O'Day, Jeffrey Weber, Claus Garbe, Celeste Lebbe, Jean-François Baurain, Alessandro Testori, Jean-Jacques Grob, Neville Davidson, Jon Richards, Michele Maio, Axel Hauschild, Wilson H Miller, Pere Gascon, Michal Lotem, Kaan Harmankaya, Ramy Ibrahim, Stephen Francis, Tai-Tsang Chen, Rachel Humphrey, Axel Hoos, Jedd D Wolchok. less N Engl J Med, 2011 Jun 07; 364(26). PMID: 21639810 Highly Cited.
|
In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy. Sean P Arlauckas, Christopher S Garris, +9 authors, Rainer H Kohler, Maya Kitaoka, Michael F Cuccarese, Katherine S Yang, Miles A Miller, Jonathan C Carlson, Gordon J Freeman, Robert M Anthony, Ralph Weissleder, Mikael J Pittet. less Sci Transl Med, 2017 May 12; 9(389). PMID: 28490665 Free PMC article. Highly Cited.
|
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma. Tyler R Simpson, Fubin Li, +11 authors, Welby Montalvo-Ortiz, Manuel A Sepulveda, Katharina Bergerhoff, Frederick Arce, Claire Roddie, Jake Y Henry, Hideo Yagita, Jedd D Wolchok, Karl S Peggs, Jeffrey V Ravetch, James P Allison, Sergio A Quezada. less J Exp Med, 2013 Jul 31; 210(9). PMID: 23897981 Free PMC article. Highly Cited.
|
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints. Shohei Koyama, Esra A Akbay, +23 authors, Yvonne Y Li, Grit S Herter-Sprie, Kevin A Buczkowski, William G Richards, Leena Gandhi, Amanda J Redig, Scott J Rodig, Hajime Asahina, Robert E Jones, Meghana M Kulkarni, Mari Kuraguchi, Sangeetha Palakurthi, Peter E Fecci, Bruce E Johnson, Pasi A Janne, Jeffrey A Engelman, Sidharta P Gangadharan, Daniel B Costa, Gordon J Freeman, Raphael Bueno, F Stephen Hodi, Glenn Dranoff, Kwok-Kin Wong, Peter S Hammerman. less Nat Commun, 2016 Feb 18; 7. PMID: 26883990 Free PMC article. Highly Cited.
|
CTLA-4⁺ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis. Hyun-Bae Jie, Patrick J Schuler, +5 authors, Steve C Lee, Raghvendra M Srivastava, Athanassios Argiris, Soldano Ferrone, Theresa L Whiteside, Robert L Ferris. less Cancer Res, 2015 Apr 03; 75(11). PMID: 25832655 Free PMC article. Highly Cited.
|
The blockade of immune checkpoints in cancer immunotherapy. Drew M Pardoll. Nat Rev Cancer, 2012 Mar 23; 12(4). PMID: 22437870 Free PMC article. Highly Cited. Review.
|
Tumor-associated macrophages in cancers. W Hu, X Li, +3 authors, C Zhang, Y Yang, J Jiang, C Wu. less Clin Transl Oncol, 2015 Aug 13; 18(3). PMID: 26264497 Review.
|
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer. Julie Brahmer, Karen L Reckamp, +22 authors, Paul Baas, Lucio Crinò, Wilfried E E Eberhardt, Elena Poddubskaya, Scott Antonia, Adam Pluzanski, Everett E Vokes, Esther Holgado, David Waterhouse, Neal Ready, Justin Gainor, Osvaldo Arén Frontera, Libor Havel, Martin Steins, Marina C Garassino, Joachim G Aerts, Manuel Domine, Luis Paz-Ares, Martin Reck, Christine Baudelet, Christopher T Harbison, Brian Lestini, David R Spigel. less N Engl J Med, 2015 Jun 02; 373(2). PMID: 26028407 Free PMC article. Highly Cited.
|
Pembrolizumab versus Ipilimumab in Advanced Melanoma. Caroline Robert, Jacob Schachter, +20 authors, Georgina V Long, Ana Arance, Jean Jacques Grob, Laurent Mortier, Adil Daud, Matteo S Carlino, Catriona McNeil, Michal Lotem, James Larkin, Paul Lorigan, Bart Neyns, Christian U Blank, Omid Hamid, Christine Mateus, Ronnie Shapira-Frommer, Michele Kosh, Honghong Zhou, Nageatte Ibrahim, Scot Ebbinghaus, Antoni Ribas, KEYNOTE-006 investigators. less N Engl J Med, 2015 Apr 22; 372(26). PMID: 25891173 Highly Cited.
|
Multiple structural and epigenetic defects in the human leukocyte antigen class I antigen presentation pathway in a recurrent metastatic melanoma following immunotherapy. Chien-Chung Chang, Giuseppe Pirozzi, +6 authors, Shao-Hsuan Wen, I-Hsin Chung, Bau-Lin Chiu, Simona Errico, Monica Luongo, Maria Luisa Lombardi, Soldano Ferrone. less J Biol Chem, 2015 Sep 19; 290(44). PMID: 26381407 Free PMC article.
|
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. Kaori Sakuishi, Lionel Apetoh, +3 authors, Jenna M Sullivan, Bruce R Blazar, Vijay K Kuchroo, Ana C Anderson. less J Exp Med, 2010 Sep 08; 207(10). PMID: 20819927 Free PMC article. Highly Cited.
|
The IFN gamma receptor: a paradigm for cytokine receptor signaling. E A Bach, M Aguet, R D Schreiber. Annu Rev Immunol, 1997 Jan 01; 15. PMID: 9143700 Highly Cited. Review.
|
Resistance to PD1/PDL1 checkpoint inhibition. Jake S O'Donnell, Georgina V Long, +2 authors, Richard A Scolyer, Michele W L Teng, Mark J Smyth. less Cancer Treat Rev, 2016 Dec 13; 52. PMID: 27951441 Highly Cited. Review.
|
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study. Joshua Bauml, Tanguy Y Seiwert, +15 authors, David G Pfister, Francis Worden, Stephen V Liu, Jill Gilbert, Nabil F Saba, Jared Weiss, Lori Wirth, Ammar Sukari, Hyunseok Kang, Michael K Gibson, Erminia Massarelli, Steven Powell, Amy Meister, Xinxin Shu, Jonathan D Cheng, Robert Haddad. less J Clin Oncol, 2017 Mar 23; 35(14). PMID: 28328302 Free PMC article. Highly Cited.
|
Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Marta Santisteban, Jennifer M Reiman, +10 authors, Michael K Asiedu, Marshall D Behrens, Aziza Nassar, Kimberly R Kalli, Paul Haluska, James N Ingle, Lynn C Hartmann, Masoud H Manjili, Derek C Radisky, Soldano Ferrone, Keith L Knutson. less Cancer Res, 2009 Mar 12; 69(7). PMID: 19276366 Free PMC article. Highly Cited.
|
Acquired resistance to immunotherapy and future challenges. Nicholas P Restifo, Mark J Smyth, Alexandra Snyder. Nat Rev Cancer, 2016 Jan 30; 16(2). PMID: 26822578 Free PMC article. Highly Cited.
|
Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure. Philippe Armand, Margaret A Shipp, +8 authors, Vincent Ribrag, Jean-Marie Michot, Pier Luigi Zinzani, John Kuruvilla, Ellen S Snyder, Alejandro D Ricart, Arun Balakumaran, Shelonitda Rose, Craig H Moskowitz. less J Clin Oncol, 2016 Jun 30; 34(31). PMID: 27354476 Free PMC article. Highly Cited.
|
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy. Jianjun Gao, Lewis Zhichang Shi, +13 authors, Hao Zhao, Jianfeng Chen, Liangwen Xiong, Qiuming He, Tenghui Chen, Jason Roszik, Chantale Bernatchez, Scott E Woodman, Pei-Ling Chen, Patrick Hwu, James P Allison, Andrew Futreal, Jennifer A Wargo, Padmanee Sharma. less Cell, 2016 Sep 27; 167(2). PMID: 27667683 Free PMC article. Highly Cited.
|
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma. Jesse M Zaretsky, Angel Garcia-Diaz, +26 authors, Daniel S Shin, Helena Escuin-Ordinas, Willy Hugo, Siwen Hu-Lieskovan, Davis Y Torrejon, Gabriel Abril-Rodriguez, Salemiz Sandoval, Lucas Barthly, Justin Saco, Blanca Homet Moreno, Riccardo Mezzadra, Bartosz Chmielowski, Kathleen Ruchalski, I Peter Shintaku, Phillip J Sanchez, Cristina Puig-Saus, Grace Cherry, Elizabeth Seja, Xiangju Kong, Jia Pang, Beata Berent-Maoz, Begoña Comin-Anduix, Thomas G Graeber, Paul C Tumeh, Ton N M Schumacher, Roger S Lo, Antoni Ribas. less N Engl J Med, 2016 Jul 20; 375(9). PMID: 27433843 Free PMC article. Highly Cited.
|
Regulatory T cells: a potential target in cancer immunotherapy. Kohei Shitara, Hiroyoshi Nishikawa. Ann N Y Acad Sci, 2018 Mar 23; 1417(1). PMID: 29566262 Highly Cited. Review.
|
PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma. Stephen M Ansell, Alexander M Lesokhin, +16 authors, Ivan Borrello, Ahmad Halwani, Emma C Scott, Martin Gutierrez, Stephen J Schuster, Michael M Millenson, Deepika Cattry, Gordon J Freeman, Scott J Rodig, Bjoern Chapuy, Azra H Ligon, Lili Zhu, Joseph F Grosso, Su Young Kim, John M Timmerman, Margaret A Shipp, Philippe Armand. less N Engl J Med, 2014 Dec 09; 372(4). PMID: 25482239 Free PMC article. Highly Cited.
|
Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer. Ruea-Yea Huang, Ariel Francois, +2 authors, Aj Robert McGray, Anthony Miliotto, Kunle Odunsi. less Oncoimmunology, 2017 Feb 16; 6(1). PMID: 28197366 Free PMC article. Highly Cited.
|
The future of immune checkpoint therapy. Padmanee Sharma, James P Allison. Science, 2015 Apr 04; 348(6230). PMID: 25838373 Highly Cited. Review.
|